Table 3 Resistance pattern of vaginal E. coli isolates to antibacterial agents
Antibacterial agent* | % of Resistant isolates | |||||
|---|---|---|---|---|---|---|
Pregnant women's isolates | Non-pregnant women's isolates | All isolates | ||||
| Â | Total (n = 19) | ESBL+(n = 14) | Total (n = 32) | ESBL+(n = 18) | Total (n = 51) | ESBL+(n = 32) |
Gentamicin | 36.8 | 50.0 | 18.75 | 27.7 | 25.4 | 37.5 |
Kanamicin | 26.3 | 35.7 | 43.7 | 50.0 | 37.2 | 43.7 |
Ciprofloxacin | 31.5 | 42.8 | 28.1 | 38.8 | 29.4 | 40.6 |
Norfloxacin | 26.3 | 35.7 | 21.8 | 27.7 | (21.5 | 31.2 |
Trimethoprim-sulfamethoxazole | 31.5 | 42.8 | 53.1 | 72.2 | 45.0 | 59.3 |
Meropenem | 0 | 0 | 0 | 0 | 0 | 0 |
Imipenem | 0 | 0 | 0 | 0 | 0 | 0 |
Amoxicillin-clavulanic acid | 100 | 100 | 100 | 100 | 100 | 100 |
Cefotaxime | 100 | 100 | 78.1 | 91.3 | 86.2 | 93.7 |
Ceftazidime | 57.8 | 76.4 | 71.8 | 78.2 | 66.6 | 81.2 |
Ceftriaxone | 42.1 | 57.1 | 46.8 | 61.1 | 45.0 | 59.3 |
Aztreonam | 42.1 | 57.1 | 46.8 | 61.1 | 45.0 | 59.3 |
% Multidrug resistance | 36.8 | 50.0 | 50.0 | 61.1 | 45.0 | 56.2 |